Anette Lodvir Hemsing's picture

Anette Lodvir Hemsing

PhD Candidate
  • E-mailanette.hemsing@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae. Translational Oncology.
  • Show author(s) (2022). NPM1-mutated patient-derived AML cells are more vulnerable to rac1 inhibition. Biomedicines. 16 pages.
  • Show author(s) (2022). MicroRNA serum profiles and chronic graft-versus-host disease. Blood Advances. 5295-5306.
  • Show author(s) (2022). Heterogeneity of patient-derived acute myeloid leukemia cells subjected to SYK in vitro inhibition. International Journal of Molecular Sciences. 21 pages.
  • Show author(s) (2022). Ekstrem hypertriglyseridemi. Tidsskrift for Den norske legeforening. 1406-1406.
  • Show author(s) (2019). Severe Nephritis as Initial Sign of Waldenström's Macroglobulinemia. Clinics and Practice. 127-132.
  • Show author(s) (2022). Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia. Expert Review of Proteomics. 73-76.
Short communication
  • Show author(s) (2019). Mondor's disease after extensive training with Nordic walking. Oxford Medical Case Reports. 356-358.
Academic literature review
  • Show author(s) (2021). Immunoglobulin-storing histiocytosis: A case based systemic review. Journal of Clinical Medicine. 21 pages.
  • Show author(s) (2020). Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterranean Journal of Hematology and Infectious Diseases (MJHID). 1-19.
  • Show author(s) (2019). Trisomy 8 in acute myeloid leukemia. Expert Review of Hematology. 947-958.

More information in national current research information system (CRIStin)